Concepedia

Piotr Szczudlik

PS

15

Publications

1.4K

Citations

13

H-Index

2010

Active since

Affiliations

Medical University of Warsaw(Current)

Oslo University Hospital

Inserm

University of Belgrade

Istanbul University

Piotr Szczudlik is an author at Medical University of Warsaw specializing in medicine, autoimmune disease, and pathology.

ORCID

Top concepts

Publications per year

2010–2022

15

Publications

15

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 587 citations · Full text

,

A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis

Paraskevi Zisimopoulou, Panagiota Evangelakou, John Tzartos et al. · Journal of Autoimmunity · 2013 · 317 citations · Full text

, , +4

MuSK autoantibodies in myasthenia gravis detected by cell based assay — A multinational study

Anastasios Tsonis, Paraskevi Zisimopoulou, Konstantinos Lazaridis et al. · Journal of Neuroimmunology · 2015 · 79 citations · Full text

, , +7

Antititin antibody in early- and late-onset myasthenia gravis

Piotr Szczudlik, Beata Szyluk, Marta Lipowska et al. · Acta Neurologica Scandinavica · 2014 · 76 citations

Titin antibodies in “seronegative” myasthenia gravis — A new role for an old antigen

Christos Stergiou, Konstantinos Lazaridis, Vasiliki Zouvelou et al. · Journal of Neuroimmunology · 2016 · 71 citations

, , +6

Rows per page

1–5 of 15